Clinical Trials

FDA approves Dymicron’s study of cervical artificial disc

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to initiate a pivotal trial of its Triadyme-C...

Radical Catheter Technologies’ catheter demonstrates positive performance

Radical Catheter Technologies™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing the next generation of endovascular access...

PanTher Therapeutics launches second trial for chemotherapy patch

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The Phase Ib study (NCT06673017)...

InterShunt enrolls first patient in heart failure treatment study

InterShunt Technologies announced it began an early feasibility study of its device for reducing heart failure symptoms. Dr. Sitaramesh Emani and the Structural Heart Intervention...

Foldax presents positive data for its Tria polymer mitral heart valve

Foldax announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering. In a trial based in India, the mitral valve...

STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation

STENTiT, a pioneering medical device company, developing a novel class of stents with regenerative properties, today announced the successful implantation of its Resorbable Fibrillated...

E2 concludes enrolment of pulmonary embolism thrombectomy system trial

Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System. The investigational device...

Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

A new study has demonstrated proof of concept for a Biolinq continuous sensor in preventing muscle loss during GLP-1 therapy. Investigators presented findings as a...

Ancora Heart reaches enrollment milestone in pivotal heart failure device trial

Ancora Heart announced it has reached the first enrollment milestone in its CORCINCH-HF pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System for...
1...567...58Page 6 of 58

Latest articles